The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs
Open accessAbstract
Nanocrystals, a carrier-free colloidal delivery system in nano-sized range, is an interesting approach for poorly soluble drugs. Nanocrystals provide special features including enhancement of saturation solubility, dissolution velocity and adhesiveness to surface/cell membranes. Several strategies are applied for nanocrystals production including precipitation, milling, high pressure homogenization and combination methods such as NanoEdge™, SmartCrystal and Precipitation-lyophilization-homogenization (PLH) technology. For oral administration, many publications reported useful advantages of nanocrystals to improve in vivo performances i.e. pharmacokinetics, pharmacodynamics, safety and targeted delivery which were discussed in this review. Additionally, transformation of nanocrystals to final formulations and future trends of nanocrystals were also described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation
KECK, C., & MULLER, R. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.05.009 · Cited by 1,061
Nanosizing — Oral formulation development and biopharmaceutical evaluation
Kesisoglou, F., Panmai, S., & Wu, Y. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.003 · Cited by 1,055
Nanocrystal technology, drug delivery and clinical applications
Müller, R., & Junghanns (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s595 · Cited by 953
Liversidge, G. G., & Cundy, K. C. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00122-y · Cited by 739
Van Eerdenbrugh, B., Van den Mooter, G., & Augustijns, P. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.023 · Cited by 717
Müller, R. H., Gohla, S., & Keck, C. M. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.01.007 · Cited by 702
Nanonization strategies for poorly water-soluble drugs
Chen, H., Khemtong, C., Yang, X., Chang, X., & Gao, J. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2010.02.009 · Cited by 642
Merisko-Liversidge, E., & Liversidge, G. G. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.12.007 · Cited by 608
Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds
Merisko-Liversidge, E. M., & Liversidge, G. G. (2008) · Toxicologic Pathology · doi:10.1177/0192623307310946 · Cited by 579
Sinha, B., Müller, R. H., & Möschwitzer, J. P. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.01.019 · Cited by 523
Cited by
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Therapeutic Nanoparticles and Their Targeted Delivery Applications
Yetisgin, A. A., Cetinel, S., Zuvin, M., Kosar, A., & Kutlu, O. (2020) · Molecules · doi:10.3390/molecules25092193 · Cited by 1,080
Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics
Bhalani, D. V., Nutan, B., Kumar, A., & Singh Chandel, A. K. (2022) · Biomedicines · doi:10.3390/biomedicines10092055 · Cited by 704
Nanoparticles: Taking a Unique Position in Medicine
Joseph, T., Kar Mahapatra, D., Esmaeili, A., Piszczyk, Ł., Hasanin, M., Kattali, M., Haponiuk, J., & Thomas, S. (2023) · Nanomaterials · doi:10.3390/nano13030574 · Cited by 480
Multifunctional nanocrystals for cancer therapy: a potential nanocarrier
Joseph, E., & Singhvi, G. (2019) · Nanomaterials for Drug Delivery and Therapy · doi:10.1016/b978-0-12-816505-8.00007-2 · Cited by 367
Nanocrystals of Poorly Soluble Drugs: Drug Bioavailability and Physicochemical Stability
Gigliobianco, M. R., Casadidio, C., Censi, R., & Di Martino, P. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030134 · Cited by 366
Nanoscale Drug Delivery Systems: From Medicine to Agriculture
Vega-Vásquez, P., Mosier, N. S., & Irudayaraj, J. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00079 · Cited by 323
Progress, challenges, and future of nanomedicine
Zhang, C., Yan, L., Wang, X., Zhu, S., Chen, C., Gu, Z., & Zhao, Y. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101008 · Cited by 318
Kinetic Modeling to Explain the Release of Medicine from Drug Delivery Systems
Askarizadeh, M., Esfandiari, N., Honarvar, B., Sajadian, S. A., & Azdarpour, A. (2023) · ChemBioEng Reviews · doi:10.1002/cben.202300027 · Cited by 318
Qi, J., Hu, X., Dong, X., Lu, Y., Lu, H., Zhao, W., & Wu, W. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.05.009 · Cited by 292
Padrela, L., Rodrigues, M. A., Duarte, A., Dias, A. M. A., Braga, M. E. M., & de Sousa, H. C. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.010 · Cited by 262
Kim, E. A., Park, J. S., Kim, M. S., Jeong, M. Y., Park, H. J., Choi, J. H., Seo, J. H., Choi, Y. S., & Kang, M. J. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s335039 · Cited by 32
“A decrease in particle size leads to an increase in surface area, which is favorable for the adhesion of drug particles to biological membranes.(26,27) Moreover, the increased dissolution rate and saturation solubility intensifies the concentration gradient between the biological membranes including stratum corneum an…”
Metadata
- Authors
- Junyaprasert, V. B., & Morakul, B.
- Venue
- Asian Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 10
- Issue
- 1
- Pages
- 13-23
- ISSN
- 1818-0876 (ISSN-L)
- OpenAlex
- W2105502591
- Cited by
- 443
- References
- 47
- FWCI
- 12.54
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.